Stockscreener 앱 받기
61.85
1.54%
-0.97
전일 마감가:
$62.82
열려 있는:
$62.91
하루 거래량:
360.35K
Relative Volume:
0.58
시가총액:
$1.32B
수익:
$56.54M
순이익/손실:
$-30.70M
주가수익비율:
-158.59
EPS:
-0.39
순현금흐름:
$-31.05M
1주 성능:
+3.15%
1개월 성능:
+25.38%
6개월 성능:
+227.08%
1년 성능:
+417.57%
1일 변동 폭
$60.73
$63.84
1주일 범위
$54.91
$66.94
52주 변동 폭
$10.14
$66.94
Cidara Therapeutics Inc Stock (CDTX) Company Profile
명칭
Cidara Therapeutics Inc
전화
858-752-6170
주소
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
CDTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
61.85 | 1.39B | 56.54M | -30.70M | -31.05M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-03-12 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-01-27 | 재개 | Cantor Fitzgerald | Overweight |
| 2024-12-13 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-08 | 개시 | Guggenheim | Buy |
| 2024-08-14 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | 재개 | H.C. Wainwright | Buy |
| 2021-09-22 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | 개시 | Aegis Capital | Buy |
| 2019-09-04 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2018-07-26 | 개시 | Citigroup | Buy |
| 2017-04-21 | 개시 | Raymond James | Strong Buy |
| 2017-04-17 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-12 | 개시 | Ladenburg Thalmann | Buy |
| 2017-04-11 | 재개 | Wedbush | Outperform |
| 2017-02-22 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-22 | 업그레이드 | WBB Securities | Sell → Hold |
| 2016-12-21 | 재개 | Leerink Partners | Outperform |
| 2016-12-19 | 개시 | H.C. Wainwright | Buy |
| 2016-09-23 | 다운그레이드 | WBB Securities | Hold → Sell |
| 2015-10-09 | 업그레이드 | WBB Securities | Sell → Hold |
| 2015-05-11 | 개시 | Jefferies | Buy |
| 2015-05-11 | 개시 | Leerink Partners | Outperform |
| 2015-05-11 | 개시 | Needham | Buy |
| 2015-05-11 | 개시 | Wedbush | Outperform |
| 2015-04-23 | 개시 | WBB Securities | Sell |
모두보기
Cidara Therapeutics Inc 주식(CDTX)의 최신 뉴스
Why Cidara Therapeutics Inc. stock attracts strong analyst attentionSwing Trade Signals - Metal.it
Cidara Therapeutics Inc. Stock Analysis and ForecastHigh-profit stock alerts - PrintWeekIndia
What drives Cidara Therapeutics Inc. stock priceTriple-digit growth rates - PrintWeekIndia
Will Cidara Therapeutics Inc. stock benefit from interest rate changesRapid market gains - jammulinksnews.com
What analysts say about Cidara Therapeutics Inc. stockRapid market gains - PrintWeekIndia
Cidara Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 - 富途牛牛
Cidara Therapeutics Sets Q2 Earnings Date: Key Updates on DFC Immunotherapy Platform Expected - Stock Titan
Is Cidara Therapeutics Inc. a good long term investmentMarket-beating returns - Autocar Professional
Cidara more than doubles on phase 2 flu preventative data - MSN
(CDTX) On The My Stocks Page - news.stocktradersdaily.com
ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews
Growth or Bubble? Unpacking CDTX Stock Surge - timothysykes.com
Cidara Therapeutics (CDTX) up more than 200% since Jun 20 - AInvest
Cidara Therapeutics stock hits 52-week high at 56.85 USD By Investing.com - Investing.com India
Cidara Therapeutics stock hits 52-week high at 56.85 USD - Investing.com
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Brokerages - Defense World
What makes Cidara Therapeutics Inc. stock price move sharplyWatchlist Winner Update - Newser
Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com
Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire
Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Cidara Therapeutics shares fall 5.99% after-hours following inducement grants announcement. - AInvest
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains - TradingView
hVIVO reports positive results from Cidara’s Phase 2b influenza study By Investing.com - Investing.com Canada
(CDTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Phathom Pharmaceuticals shares rise 1.47% premarket after Cidara Therapeutics closes $402.5 million stock offering. - AInvest
Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN
Cidara Therapeutics Advances CD388 To Phase 3, Reiterated Buy (NASDAQ:CDTX) - Seeking Alpha
Cidara Therapeutics (CDTX) Price Target Raised by RBC Capital | CDTX Stock News - GuruFocus
Cidara Therapeutics Inc (CDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cidara Therapeutics Inc 주식 (CDTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mineo Chrysa | Director |
Jun 02 '25 |
Buy |
21.71 |
2,270 |
49,281 |
2,270 |
| Mineo Chrysa | Director |
Jun 03 '25 |
Buy |
23.44 |
1,050 |
24,614 |
3,320 |
| Ward Shane | COO & CLO |
Mar 11 '25 |
Sale |
21.96 |
1,664 |
36,542 |
14,674 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Mar 11 '25 |
Sale |
21.96 |
1,773 |
38,940 |
16,215 |
| Sandison Taylor | Chief Medical Officer |
Sep 11 '24 |
Sale |
11.64 |
924 |
10,752 |
23,067 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Sep 11 '24 |
Sale |
11.64 |
909 |
10,580 |
17,788 |
0.97%
0.22%
자본화:
|
볼륨(24시간):